A carregar...

Synergy of Combined tPA-Edaravone Therapy in Experimental Thrombotic Stroke

Edaravone, a potent antioxidant, may improve thrombolytic therapy because it benefits ischemic stroke patients on its own and mitigates adverse effects of tissue plasminogen activator (tPA) in preclinical models. However, whether the combined tPA-edaravone therapy is more effective in reducing infar...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sun, Yu-Yo, Morozov, Yury M., Yang, Dianer, Li, Yikun, Dunn, R. Scott, Rakic, Pasko, Chan, Pak H., Abe, Koji, Lindquist, Diana M., Kuan, Chia-Yi
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4049665/
https://ncbi.nlm.nih.gov/pubmed/24911517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0098807
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!